Introduction: When Technology Begins to Heal Like Nature In the evolving landscape of biomedical innovation, few technologies embody the convergence of science, engineering, and human compassion as profoundly as bioprinting. The idea that living tissues—once considered exclusive to the natural processes of biology—can now be engineered, layer by layer, through sophisticated printing systems marks a paradigm shift in modern medicine.…
bioprinting
Biologics for Billions: The Biosimilar Civilization Beyond 2040
The story of biosimilars beyond 2040 is not merely a scientific extension of recombinant DNA technology; it is the unfolding architecture of therapeutic democratization. If the twentieth century was the era of antibiotics and small molecules, and the early twenty-first century the age of monoclonal antibodies and targeted biologics, then the decades beyond 2040 will be remembered as the epoch…
The Molecule Republic: India’s Pharmaceutical Renaissance Beyond 2040
A Strategic Narrative on Sovereignty, Science, and the Ethics of Scale When historians of industry write about India beyond 2040, they may not describe it merely as the “pharmacy of the world.” That phrase, powerful in its time, captured a phase — an era defined by generics, vaccines, cost leadership, and supply resilience. But the decades after 2040 will demand…
The Beating Blueprint: India’s Quest to Biofabricate the Human HeartFrom Regenerative Imagination to Sovereign Biomedical Reality
By Devanssh Mehta, M.Pharm., MBA, B.Pharm. There are moments in the history of medicine when science ceases to be merely diagnostic or therapeutic and becomes creative in the truest biological sense. The aspiration to bioprint a human heart belongs to that rare category. It is not an incremental refinement of surgery, nor simply a novel pharmaceutical intervention. It is an…
Printing Hope, Engineering Life: India’s Ascent Toward the Bioprinted Liver
From Hepatic Failure to Regenerative Sovereignty — Reimagining Organ Replacement in the Age of Biofabrication The story of modern healthcare in India is a story of paradox. On one hand, the nation has earned global recognition as the “Pharmacy of the World,” mastering the science of generics, vaccine scale-up, and affordable therapeutic manufacturing. On the other hand, India continues to…
